Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

2.3. Study procedures

ME Masoud Etemadifar
NS Nahad Sedaghat
HN Hosein Nouri
NL Noushin Lotfi
AC Ahmad Chitsaz
RK Reza Khorvash
HZ Hamed Zolfaghari
AM Alireza Ghasemi Movaghar
MP Mohammad Pourabbas
MS Mehri Salari
ask Ask a question
Favorite

To avoid referring immunocompromised pwMS to the laboratory, an experienced mobile phlebotomist was sent to obtain and bring back samples from the participants of the DMT-exposed cohort at their own houses. The phlebotomist was further instructed to follow strict preventive protocols and to obtain the samples as quickly as possible, to ensure the least direct contact with the immunocompromised pwMS. As mentioned, the participants of the UX cohort underwent phlebotomy at the laboratory before being included in the study. All samples included five milliliters of blood, which were used to prepare sera and stored at −20 °C until further analyses were run.

Copyright and License information:  ©2021 Published by Elsevier B.V.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A